학술논문

Interruptin B induces brown adipocyte differentiation and glucose consumption in adipose-derived stem cells
Document Type
Report
Source
Molecular Medicine Reports. March 1, 2016, p2078, 9 p.
Subject
Models
Genetic aspects
Growth
Properties
Health aspects
Company growth
Cell differentiation -- Genetic aspects -- Health aspects
Adipocytes -- Growth
Glucose metabolism -- Models
Diabetes therapy -- Models
Biological products -- Properties
Fat cells -- Growth
Language
English
ISSN
1791-2997
Abstract
Introduction Obesity can be defined not only as excess body weight, but also as an increased accumulation of adipose tissue. Obesity is a risk factor for chronic diseases, including hypertension, [...]
Interruptin B has been isolated from Cyclosorus terminans, however, its pharamcological effect has not been fully identified. In the present study, the effects of interruptin B, from C. terminans, on brown adipocyte differentiation and glucose uptake in adipose-derived stem cells (ASCs) were investigated. The results revealed that interruptin B dose-dependently enhanced the adipogenic differentiation of ASCs, with an induction in the mRNA expression levels of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ. In addition, interruptin B efficiently increased the number and the membrane potential of mitochondria and upregulated the mRNA expression levels of uncoupling protein (UCP)-1 and cyclooxygenase (COX)-2, which are all predominantly expressed in brown adipocytes. Interruptin B increased glucose consumption in differentiated ASCs, accompanied by the upregulation in the mRNA expression levels of glucose transporter (GLUT)-1 and GLUT-4. The computational analysis of molecular docking, a luciferase reporter assay and surface plasmon resonance confirmed the marked binding affinity of interruptin B to PPAR-α and PPAR-γ ([K.sub.D] values of 5.32 and 0.10 µm, respectively). To the best of our knowledge, the present study is the first report to show the stimulatory effects of interruptin B on brown adipocyte differentiation and glucose uptake in ASCs, through its role as a dual PPAR-α and PPAR-γ ligand. Therefore, interruptin B could be further developed as a therapeutic agent for the treatment of diabetes. Key words: interruptin B, Cyclosorus terminans, adipose-derived stem cell, brown adipocyte, peroxisome proliferator-activated receptors, glucose uptake